TriMas Co. (NASDAQ:TRS) Stake Lessened by Thrivent Financial for Lutherans

Thrivent Financial for Lutherans trimmed its holdings in shares of TriMas Co. (NASDAQ:TRS – Get Rating) by 2.9% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 24,931 shares of the industrial products company’s stock after selling 740 shares during the period. Thrivent Financial for Lutherans owned about 0.06% of TriMas worth $691,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Pzena Investment Management LLC boosted its stake in TriMas by 15.2% in the 4th quarter. Pzena Investment Management LLC now owns 1,934,414 shares of the industrial products company’s stock worth $53,661,000 after purchasing an additional 254,948 shares during the period. SG Americas Securities LLC grew its position in TriMas by 8.4% during the fourth quarter. SG Americas Securities LLC now owns 10,913 shares of the industrial products company’s stock worth $303,000 after buying an additional 848 shares in the last quarter. River Road Asset Management LLC grew its position in TriMas by 1.1% during the fourth quarter. River Road Asset Management LLC now owns 1,470,016 shares of the industrial products company’s stock worth $40,778,000 after buying an additional 16,139 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its position in TriMas by 36.2% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 6,916 shares of the industrial products company’s stock worth $192,000 after buying an additional 1,840 shares in the last quarter. Finally, Sendero Wealth Management LLC acquired a new stake in TriMas during the fourth quarter worth about $245,000. 99.94% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research analysts have recently commented on TRS shares. BWS Financial started coverage on TriMas in a report on Monday. They issued a “buy” rating and a $40.00 target price on the stock. TheStreet cut shares of TriMas from a “b” rating to a “c” rating in a research report on Monday, May 1st. Finally, StockNews.com started coverage on shares of TriMas in a research report on Thursday, May 18th. They issued a “hold” rating for the company.

TriMas Price Performance

Shares of NASDAQ TRS opened at $26.03 on Thursday. The firm has a market cap of $1.08 billion, a PE ratio of 19.14 and a beta of 0.71. The company has a current ratio of 2.63, a quick ratio of 1.48 and a debt-to-equity ratio of 0.61. TriMas Co. has a 1-year low of $21.41 and a 1-year high of $31.89. The company has a fifty day moving average price of $26.47 and a 200 day moving average price of $27.89.

TriMas (NASDAQ:TRS – Get Rating) last posted its quarterly earnings data on Thursday, April 27th. The industrial products company reported $0.30 EPS for the quarter, topping analysts’ consensus estimates of $0.27 by $0.03. TriMas had a net margin of 6.50% and a return on equity of 10.49%. The company had revenue of $215.50 million during the quarter, compared to the consensus estimate of $208.00 million. During the same period in the prior year, the business posted $0.50 EPS. The company’s quarterly revenue was down 3.9% on a year-over-year basis. Research analysts predict that TriMas Co. will post 2.06 earnings per share for the current fiscal year.

TriMas Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, May 11th. Stockholders of record on Thursday, May 4th were paid a dividend of $0.04 per share. The ex-dividend date was Wednesday, May 3rd. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.61%. TriMas’s dividend payout ratio is 11.76%.

Insider Transactions at TriMas

In other TriMas news, Director Jeffrey A. Fielkow acquired 1,000 shares of TriMas stock in a transaction dated Thursday, May 4th. The stock was bought at an average cost of $25.26 per share, for a total transaction of $25,260.00. Following the purchase, the director now directly owns 4,445 shares in the company, valued at approximately $112,280.70. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. In other news, CFO Scott A. Mell sold 1,150 shares of the company’s stock in a transaction dated Friday, May 12th. The shares were sold at an average price of $25.41, for a total value of $29,221.50. Following the sale, the chief financial officer now directly owns 28,518 shares of the company’s stock, valued at approximately $724,642.38. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Jeffrey A. Fielkow bought 1,000 shares of the company’s stock in a transaction dated Thursday, May 4th. The stock was purchased at an average cost of $25.26 per share, for a total transaction of $25,260.00. Following the completion of the acquisition, the director now owns 4,445 shares in the company, valued at approximately $112,280.70. The disclosure for this purchase can be found here. Insiders acquired a total of 1,027 shares of company stock worth $26,008 in the last three months. Insiders own 1.10% of the company’s stock.

About TriMas

(Get Rating)

TriMas Corp. engages in the manufacture of industrial products for customers in the consumer products, aerospace, industrial, petrochemical, refinery, and oil and gas end markets. It operates through the following segments: Packaging, Aerospace, and Specialty Products. The Packaging segment designs and manufactures dispensing products, including foaming pumps, lotion and hand soap pumps, sanitizer pumps, beverage dispensers, perfume sprayers, nasal sprayers and trigger sprayers, polymeric and steel caps and closures, including food lids, flip-top closures, child resistant caps, drum and pail closures, and flexible spouts, polymeric jar products, and fully integrated dispensers for fill-ready bag-in-box applications, all for a variety of consumer product markets including, but not limited to, beauty and personal care, home care, food and beverage, and pharmaceutical and nutraceutical, as well as the industrial market.